Idt Australia Ltd has released a press release.
US launch of Pindolol
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from IDT Australia
- FDA review clears Pindolol for US launch
- Appendix 3Z
- Generics Sales Update
- Completion of Initial CMAX Transaction
- Mayne Pharma Announces U.S. Launch of IDTs Temozolomide
Later from IDT Australia
- Corporate Governance Statement
- Director Retirement - Graeme Blackman
- Resignation of Managing Director
- IDT Australia: Updated Charter Audit and Risk Committee
- IDT Australia: Updated Charter Remuneration and Nomination Committee
Follow IDT Australia into a list and get an email when it puts out news.
Follow IDT Australia